Rhumbline Advisers Prime Medicine, Inc. Transaction History

Rhumbline Advisers

  • $109 Billion
  • Q3 2024

A detailed history of Rhumbline Advisers transactions in Prime Medicine, Inc. stock. As of the latest transaction made, Rhumbline Advisers holds 70,047 shares of PRME stock, worth $234,657. This represents 0.0% of its overall portfolio holdings.

Number of Shares
70,047
Previous 70,107 0.09%
Holding current value
$234,657
Previous $360,000 24.72%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
SELL
$3.41 - $6.7 $204 - $402
-60 Reduced 0.09%
70,047 $271,000
Q2 2024

Aug 01, 2024
BUY
$4.3 - $8.03 $75,658 - $141,287
17,595 Added 33.51%
70,107 $360,000
Q1 2024

May 09, 2024
BUY
$6.35 - $9.39 $10,502 - $15,531
1,654 Added 3.25%
52,512 $367,000
Q4 2023

Feb 08, 2024
SELL
$5.59 - $9.55 $564 - $964
-101 Reduced 0.2%
50,858 $450,000
Q3 2023

Nov 09, 2023
BUY
$9.5 - $15.07 $37,012 - $58,712
3,896 Added 8.28%
50,959 $486,000
Q2 2023

Aug 08, 2023
BUY
$11.41 - $17.05 $536,988 - $802,424
47,063 New
47,063 $689,000

Others Institutions Holding PRME

# of Institutions
124
Shares Held
64.7M
Call Options Held
324K
Put Options Held
64.4K
View Full List

About Prime Medicine, Inc.

PRME Quotes by TradingView
  • Ticker PRME
  • Shares Outstandng 95,730,200
  • Market Cap $321M
More about PRME
Track This Portfolio

Track Rhumbline Advisers Portfolio

Follow Rhumbline Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email